Elevance Health Inc. ($ELV) Stock Forecast: Down 0.8% Today

What is Elevance Health Inc.?

Elevance Health Inc. (NYSE: ELV) is a healthcare company that focuses on Medicare Advantage membership and Carelon revenue growth.

Why is Elevance Health Inc. going down?

ELV stock is down 0.8% on Oct 22, 2025 14:46

• Despite surpassing earnings estimates, ELV faced a downward trend attributable to Medicare cost pressures, Obamacare plan dynamics, and Medicaid attrition, influencing investor sentiment.
• The Q3 performance, marked by significant Medicare Advantage membership growth and Carelon revenue increase, was overshadowed by Medicaid losses impacting the stock's value.
• Analysts' projections concerning ELV's Q3 earnings did not fully anticipate the challenges stemming from Medicare cost pressures and Medicaid attrition, contributing to the recent bearish market trend.

ELV Price Chart

ELV Technical Analysis

ELV News

Why Is Elevance Health Stock Falling Tuesday? - Elevance Health ( NYSE:ELV )

Elevance Health, Inc. ( NYSE:ELV ) shares fell Tuesday despite beating estimates, as Medicare cost pressures, Obamacare plan dynamics, and Medicaid attrition weighed on sentiment. The company reported third-quarter adjusted earnings per share of $6.03, beating the analyst consensus estimate ...

https://www.benzinga.com/markets/earnings/25/10/48338057/elevance-healths-strong-quarter-cant-shake-off-medicaid-troubles

Elevance Health Q3 Earnings Beat Estimates on Strong MA Membership

ELV beats EPS estimates by 21% in Q3 as strong Medicare Advantage membership gains and Carelon revenue growth offset Medicaid losses.

https://www.zacks.com/stock/news/2773476/elevance-health-q3-earnings-beat-estimates-on-strong-ma-membership

Wall Street's Insights Into Key Metrics Ahead of Elevance Health ( ELV ) Q3 Earnings

Besides Wall Street's top-and-bottom-line estimates for Elevance Health (ELV), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.

https://www.zacks.com/stock/news/2770031/wall-streets-insights-into-key-metrics-ahead-of-elevance-health-elv-q3-earnings

Trending Today

FuelCell Energy ($FCEL) Stock Forecast: Up 6.0% Today

Home Depot Inc. (The) ($HD) Stock Forecast: Down 2.3% Today

Zillow Group Inc. ($Z) Stock Forecast: Down 5.1% Today

Amcor plc ($AMCR) Stock Forecast: Down 5.1% Today

Lennar Corporation Class A ($LEN) Stock Forecast: Down 2.5% Today

Martin Marietta Materials Inc. ($MLM) Stock Forecast: Down 0.3% Today

Vulcan Materials Company (Holding Company) ($VMC) Stock Forecast: Up 0.5% Today

British Pound ($GBP/USD) Forex Forecast: Down 0.9% Today

Euro ($EUR/USD) Forex Forecast: Down 0.6% Today

Cardano ($ADA) Crypto Forecast: Down 5.3% Today

Elevance Health Inc. Price History

22.09.2025 - ELV Stock was down 0.8%

• Despite surpassing earnings estimates, ELV faced a downward trend attributable to Medicare cost pressures, Obamacare plan dynamics, and Medicaid attrition, influencing investor sentiment.
• The Q3 performance, marked by significant Medicare Advantage membership growth and Carelon revenue increase, was overshadowed by Medicaid losses impacting the stock's value.
• Analysts' projections concerning ELV's Q3 earnings did not fully anticipate the challenges stemming from Medicare cost pressures and Medicaid attrition, contributing to the recent bearish market trend.

15.07.2025 - ELV Stock was up 5.0%

• Despite a recent decline in YTD performance, ELV showed a strong bullish movement today, indicating a potential turnaround in investor sentiment.
• The company's cost-cutting measures and focus on commercial growth may have positively impacted the stock price.
• Analyst pessimism and concerns over rising costs could have been overshadowed by the company's efforts to address these issues, leading to the bullish market movement.
• ELV's strategic initiatives to stabilize performance and leverage long-term growth levers seem to have resonated well with investors, driving the stock higher.

17.06.2025 - ELV Stock was down 10.5%

• ELV's Q2 revenue rose by 14.3% year-over-year, exceeding projections. However, the company reduced its FY25 EPS guidance due to increased ACA and Medicaid expenses.
• Anticipated cost escalations and decreased Medicaid enrollments are likely to impact ELV's Q2 earnings.
• Investor apprehension may stem from doubts about the company's capability to efficiently control expenses and sustain profitability in the face of tough market conditions.

17.06.2025 - ELV Stock was down 8.6%

• ELV experienced a strong bearish movement today as investors may be concerned about the company's upcoming Q2 earnings.
• Rising costs and lower Medicaid memberships are expected to pressure ELV's profits, leading to a negative market sentiment.
• The anticipation of a decline in ELV's Q2 earnings, coupled with the lack of key ingredients for a potential earnings beat, could have contributed to the bearish market movement.
• Investors are advised to closely monitor ELV's earnings and key metrics to gain a better understanding of the company's performance and future outlook.

17.06.2025 - ELV Stock was down 12.9%

• ELV's Q2 earnings fell short of expectations due to escalating medical expenses, particularly related to Medicaid and ACA.
• Despite a 14.3% increase in Q2 revenue compared to the previous year, the company adjusted its FY25 EPS forecast downwards, sparking worries among investors.
• The market responded unfavorably to the announcement of potential profit challenges arising from higher costs and decreased Medicaid enrollments.
• The convergence of earnings missing estimates, guidance revision, and apprehensions about cost pressures contributed to a significant drop in ELV's stock price today.

23.04.2025 - ELV Stock was down 5.3%

• The bearish movement in ELV's stock today can be attributed to the class action lawsuits filed against the company on behalf of its stockholders for potential violations of federal securities laws. This legal uncertainty has likely caused investor concern and led to a sell-off of ELV shares.
• The negative impact on health care stocks like ELV could have been further exacerbated by the broader market trend, as indicated by the decline in other health care companies such as UnitedHealth and CVS following CMS's announcement of audits on MA contracts.
• Investors with substantial losses in ELV are being given the opportunity to lead class action lawsuits, adding to the legal pressures faced by the company and contributing to the downward pressure on its stock price.
• The upcoming class action deadline for ELV shareholders to contact law firms further highlights the legal challenges surrounding the company, potentially leading to continued volatility in its stock performance.

02.06.2025 - ELV Stock was down 8.3%

• The upcoming court deadline for the lawsuit against Elevance Health, Inc. may have caused uncertainty and negative sentiment among investors.
• The legal issues and potential violations by the company's senior executives could be contributing to the bearish movement in ELV stock.
• Investors might be reacting to the news by selling off their positions in ELV, leading to the strong bearish movement in the stock today.

18.06.2025 - ELV Stock was down 6.1%

• ELV stock experienced a strong bearish movement today due to a series of negative news and analyst actions.
• The company's Q2 earnings missed estimates, with EPS sliding and facing pressure from rising medical costs, particularly from Medicaid and ACA expenses.
• Despite a 14.3% Y/Y increase in Q2 revenue, ELV's FY25 EPS guidance was cut below consensus, citing higher costs.
• Analyst downgrades and concerns about rising costs and lower Medicaid memberships contributed to the bearish market movement of ELV today.

18.06.2025 - ELV Stock was down 8.4%

• ELV's Q2 earnings fell short of expectations because of escalating medical expenses, mainly from Medicaid and ACA costs.
• Although there was a 14.3% rise in Q2 revenue compared to the previous year, the company reduced its projected FY25 EPS, pointing to increased ACA and Medicaid expenses as the main factors.
• Analysts issued downgrades on Elevance Health, which added to the pessimistic outlook on the stock.
• Concerns about surging costs and declining Medicaid enrollments affecting ELV's profitability in the second quarter led to a negative market response.

22.04.2025 - ELV Stock was down 5.4%

• ELV stock plummeted due to the announcement of a class action lawsuit indicating potential violations by the company and its executives, leading to investor uncertainty and selling pressure.
• The broader health care sector, including companies like UnitedHealth and CVS, also faced a downturn following regulatory actions, adding to the negative sentiment in the industry.
• Investors with substantial losses in ELV are being urged to participate in the class action lawsuit, further exacerbating the negative outlook for the company and contributing to the bearish market movement.
• The legal challenges and uncertainties surrounding Elevance Health have overshadowed its historical market outperformance, causing a sharp decline in its stock price today.

03.09.2025 - ELV Stock was up 5.2%

• ELV's bullish movement could be attributed to Cigna expanding coverage to Cleerly's AI cardiovascular imaging solutions.
• The partnership with Cigna is seen as a significant endorsement of ELV's technology, leading to increased investor confidence and driving the stock price higher.
• This development highlights the growing importance of early detection and digital healthcare solutions, positioning ELV as a key player in the evolving healthcare industry.

21.09.2025 - ELV Stock was up 0.0%

• ELV's bullish movement could be attributed to positive projections for key metrics ahead of its Q3 earnings report.
• Investors may be optimistic about the company's performance in the quarter ended September 2025, leading to increased buying activity.
• The anticipation of strong financial results and key metrics could be driving the bullish sentiment in ELV's stock today.